Influenza viruses with rearranged genomes as live-attenuated vaccines.
about
Replication-Competent Influenza A Viruses Expressing Reporter GenesAdvancements in the development of subunit influenza vaccinesOptimisations and Challenges Involved in the Creation of Various Bioluminescent and Fluorescent Influenza A Virus Strains for In Vitro and In Vivo ApplicationsReverse Genetics Approaches for the Development of Influenza VaccinesAirborne transmission of highly pathogenic H7N1 influenza virus in ferretsReplication-competent fluorescent-expressing influenza B virusMulti-Modal Imaging with a Toolbox of Influenza A Reporter VirusesIn Vivo Imaging of Influenza Virus Infection in Immunized Mice.Influenza A and B virus intertypic reassortment through compatible viral packaging signals.Illumina MiSeq sequencing disfavours a sequence motif in the GFP reporter gene.Universal influenza vaccines: Shifting to better vaccines.In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies.Genome rearrangement of influenza virus for anti-viral drug screeningA virulent bioluminescent and fluorescent dual-reporter Marek's disease virus unveils an alternative spreading pathway in addition to cell-to-cell contact.Replication-competent influenza A viruses expressing a red fluorescent protein.A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.Replication-Competent Influenza A and B Viruses Expressing a Fluorescent Dynamic Timer Protein for In Vitro and In Vivo Studies.Replication-Competent Influenza B Reporter Viruses as Tools for Screening Antivirals and Antibodies.Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it?An eight-segment swine influenza virus harboring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs.Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread.Investigating influenza A virus infection: tools to track infection and limit tropism.Adjuvant effects mediated by the carbohydrate recognition domain of Agrocybe aegerita lectin interacting with avian influenza H9N2 viral surface glycosylated proteins.Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs.Positive regulation of humoral and innate immune responses induced by inactivated Avian Influenza Virus vaccine in broiler chickens.Evolutionarily stable attenuation by genome rearrangement in a virus.Surviving another influenza threat.Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing LuciferaseDirected evolution of an influenza reporter virus to restore replication and virulence and enhance non-invasive bioluminescence imaging in mice
P2860
Q26746999-087153F3-0E78-4E3D-8D49-0E7B0DD8606FQ27010100-56B6FD97-A236-4609-B27E-1B9D76D0DB7EQ27301941-17A13F65-BD82-4713-ACD6-2D6AC411A9EFQ28076140-8469EEE6-DD03-4DE1-84BE-E5FD5B87ACDAQ28387714-AB234A85-CC70-4511-AF7E-4FF2303D43BBQ28387786-13C99882-3ED2-4ECF-941F-EE6E75709187Q28393104-52F242D7-94DC-4FB6-8869-F847D4196F5EQ30148613-C27277C6-5353-4EC8-864B-6F521351C48DQ30364518-22E3EEEB-FCBD-4275-B9BE-B6F632CBFDCCQ30382558-F8996DCD-510E-4C61-8B20-51D5A64F4F30Q30386388-1054F41E-A767-4DA2-9E63-2408D0FEBA0AQ30430923-5546F4DD-9B48-4DBC-BD77-7F20157B2892Q34053717-A26A3B99-0395-410B-BE57-4EE2326F85B3Q34261802-E3678B03-4F19-4032-B2CD-FC116951EDF8Q35071285-2E6E9079-9660-4074-8A34-B6C72DE23E5EQ35225083-58B60E02-E653-4D5E-B1C3-85CE1072E5D6Q35904047-78081BD1-3152-4A28-9D09-C7310B7E2CF4Q36281137-9DCC73BE-D5BE-497C-BA52-949EC004502DQ36738542-EE3DA327-5072-4B96-A5A2-A2A993113C89Q37123091-46732A2A-5FDB-4134-B0D9-CC96BA8D707AQ37336673-4068322D-99C8-4B81-A329-B1790EBC35C1Q38412391-75D9840B-A326-4989-8A63-6CE59B7DE6F3Q40083668-01E33170-64F1-4FBE-8E9D-949FF62C9C9FQ40156113-E181893B-A9D3-421E-B7AB-AADD6DCB0D3BQ40170317-166D90E6-B557-46B5-8713-382E543A474FQ41020987-32432634-E6F6-4E23-AC7F-10D5407EACB3Q42288506-EAE1B8EA-B69D-454C-AD24-F5E51233063AQ43170636-7E842EF6-3415-4D0D-850D-DA26C3D02074Q50308620-AA44C53B-49CF-4C5F-9EFB-A593EB4D9F2BQ56477377-BDEDA81E-3E47-4AC3-B2E3-6B6D89F26D6EQ56890034-50127188-342D-4CCB-8A10-5FE086E047A6
P2860
Influenza viruses with rearranged genomes as live-attenuated vaccines.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Influenza viruses with rearranged genomes as live-attenuated vaccines.
@ast
Influenza viruses with rearranged genomes as live-attenuated vaccines.
@en
type
label
Influenza viruses with rearranged genomes as live-attenuated vaccines.
@ast
Influenza viruses with rearranged genomes as live-attenuated vaccines.
@en
prefLabel
Influenza viruses with rearranged genomes as live-attenuated vaccines.
@ast
Influenza viruses with rearranged genomes as live-attenuated vaccines.
@en
P2093
P2860
P356
P1433
P1476
Influenza viruses with rearranged genomes as live-attenuated vaccines.
@en
P2093
Ashok Chockalingam
Hongjun Chen
Hongxia Shao
Lindomar Pena
Matthew Angel
Sachin Kumar
Troy Sutton
Weizhong Li
P2860
P304
P356
10.1128/JVI.02490-12
P577
2013-02-28T00:00:00Z